Pipenzolate bromide

Pipenzolate bromide
Clinical data
ATC code	A03AB14 (WHO) ;
Identifiers
	IUPAC name 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide;
CAS Number	125-51-9 ;
PubChem CID	657306;
ChemSpider	571430 ;
UNII	JPX41DUS2B;
ChEMBL	ChEMBL1401367 ;
CompTox Dashboard (EPA)	DTXSID2023480 ;
ECHA InfoCard	100.004.311
Chemical and physical data
Formula	C22H28BrNO3
Molar mass	434.374 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-];
	InChI InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 ; Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M ;
	(what is this?) (verify)

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.^[1]

Mechanism of action

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.^[1]

References

^ ^a ^b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

[ncats-1] "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.

[1]